[Effect of Panavir on influenza A virus reproduction]

Insights

Panavir exhibits significant mitogenic activity and acts as an immunomodulator. This compound effectively inhibits influenza virus replication in vitro and demonstrates antiviral properties against influenza A in vivo.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Context:

  • Influenza virus poses a significant public health threat, necessitating the development of novel antiviral agents.
  • Existing antiviral drugs face challenges with resistance and side effects, highlighting the need for alternative therapeutic strategies.
  • Panavir, a plant-derived compound, has shown potential in preclinical studies.

Purpose:

  • To investigate the mitogenic properties of panavir.
  • To evaluate the in vitro efficacy of panavir against influenza virus replication.
  • To assess the in vivo antiviral activity of panavir in a murine model of influenza infection.

Summary:

  • Panavir demonstrated no cytotoxic effects and significant mitogenic activity, suggesting its potential as an immunomodulator.
  • In vitro studies showed that panavir inhibited influenza virus production in cell systems, particularly at early infection stages and with lower viral doses.
  • In vivo experiments in mice revealed that panavir possesses anti-influenza activity against both remantadine-resistant and non-resistant strains of influenza A virus.

Impact:

  • Panavir's immunomodulatory and antiviral properties indicate its promise as a therapeutic agent for influenza.
  • The compound's efficacy against resistant viral strains warrants further investigation for clinical applications.
  • These findings support panavir as a potential candidate for developing new influenza treatments.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...